Core Viewpoint - Ardent Health, Inc. is under investigation for potential violations of federal securities laws due to improper accounting practices related to accounts receivable and professional liability reserves [3]. Financial Performance - On November 12, 2025, Ardent reported a $43 million decrease in revenue for Q3 2025 after conducting evaluations of historical collection trends [4]. - The company also increased its professional liability reserves by $54 million due to adverse claim developments from 2019 to 2022 and broader industry trends [4]. - Following the financial disclosures, Ardent's stock price dropped over 33% during trading on November 13, 2025 [4]. Legal Context - Bleichmar Fonti & Auld LLP is leading the investigation and encourages investors to seek additional information regarding their legal options [2][5]. - The law firm has a strong track record in securities class actions, having recovered significant amounts for shareholders in previous cases [6].
Ardent Health, Inc. (ARDT) Investors are Reminded to Contact BFA Law about its Ongoing Securities Class Action Investigation